2026 Blue Rx PDP Complete (PDP) formulary (drug list)
Contract S5593, plan 003 · West Virginia · 3,788 drugs on file · formulary ID 00026017. Each drug links to its cost in every CMS PDP Region 06 plan.
15 drugs starting with Y.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| YARGESA 100 mg CapsuleMiglustat | 5Specialty Tier | 25% | N/A |
|
| YESINTEK 45 mg/.5mL Injection, SolutionUstekinumab | 3Preferred Brand | 25% | 25% |
|
| YESINTEK 45 mg/.5mL Injection, SolutionUstekinumab | 3Preferred Brand | 25% | 25% |
|
| YESINTEK 90 mg/mL Injection, SolutionUstekinumab | 5Specialty Tier | 25% | N/A |
|
| YF-VAX 4.74 [PFU]/.5mL Injection, Powder, Lyophilized, For SuspensionYellow Fever Virus Strain 17D-204 Live Antigen | 3Preferred Brand | 25% | 25% | None |
| YONSA 125 mg TabletAbiraterone Acetate | 5Specialty Tier | 25% | N/A |
|
| YORVIPATH 168 ug/.56mL Injection, SolutionPalopegteriparatide | 5Specialty Tier | 25% | N/A |
|
| YORVIPATH 294 ug/.98mL Injection, SolutionPalopegteriparatide | 5Specialty Tier | 25% | N/A |
|
| YORVIPATH 420 ug/1.4mL Injection, SolutionPalopegteriparatide | 5Specialty Tier | 25% | N/A |
|
| YUFLYMA KitAdalimumab-Aaty | 5Specialty Tier | 25% | N/A |
|
| YUFLYMA KitAdalimumab-Aaty | 5Specialty Tier | 25% | N/A |
|
| YUFLYMA KitAdalimumab-Aaty | 5Specialty Tier | 25% | N/A |
|
| YUFLYMA KitAdalimumab-Aaty | 5Specialty Tier | 25% | N/A |
|
| YUPELRI 175 ug/3mL SolutionRevefenacin | 5Specialty Tier | 25% | N/A |
|
| YUVAFEM 10 ug TabletEstradiol | 4Non-Preferred Drug | 25% | 25% | None |
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.